Información del producto
Vicagrel is a prodrug that is hydrolyzed to clopidogrel. It is used for the prevention of atherothrombotic events in patients with chronic oral anticoagulation and chronic hepatic impairment. Vicagrel has been shown to have a matrix effect on platelets, which may be due to its inhibition of phosphodiesterase type-1 (PDE-1). This inhibition leads to an accumulation of cyclic AMP (cAMP), which causes vasodilation and increased blood flow. In addition, vicagrel has been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Vicagrel also inhibits the conversion of adenosine diphosphate (ADP) into ATP by inhibiting the enzyme adenylate kinase.
Propiedades químicas
Consulta técnica sobre: 3D-PCC08153 Vicagrel
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
